View in EDS

Host IL11 Signaling Suppresses CD4+ T cell-Mediated Antitumor Responses to Colon Cancer in Mice.

Saved in:
Bibliographic Details
Title: Host IL11 Signaling Suppresses CD4+ T cell-Mediated Antitumor Responses to Colon Cancer in Mice.
Authors: Huynh J; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Baloyan D; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Chisanga D; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Shi W; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., O'Brien M; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Afshar-Sterle S; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Alorro M; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Pang L; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Williams DS; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.; Department of Pathology, Austin Health, Heidelberg, Victoria, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia., Parslow AC; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Thilakasiri P; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Eissmann MF; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Boon L; Polpharma Biologics, Utrecht, the Netherlands., Masson F; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Chand AL; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Ernst M; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia. matthias.ernst@onjcri.org.au.
Source: Cancer immunology research [Cancer Immunol Res] 2021 Jul; Vol. 9 (7), pp. 735-747. Date of Electronic Publication: 2021 Apr 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33906864
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Host IL11 Signaling Suppresses CD4<superscript>+</superscript> T cell-Mediated Antitumor Responses to Colon Cancer in Mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Huynh+J%22">Huynh J</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Baloyan+D%22">Baloyan D</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Chisanga+D%22">Chisanga D</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Shi+W%22">Shi W</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22O'Brien+M%22">O'Brien M</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Afshar-Sterle+S%22">Afshar-Sterle S</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Alorro+M%22">Alorro M</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Pang+L%22">Pang L</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Williams+DS%22">Williams DS</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.; Department of Pathology, Austin Health, Heidelberg, Victoria, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Parslow+AC%22">Parslow AC</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Thilakasiri+P%22">Thilakasiri P</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Eissmann+MF%22">Eissmann MF</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Boon+L%22">Boon L</searchLink>; Polpharma Biologics, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Masson+F%22">Masson F</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Chand+AL%22">Chand AL</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Ernst+M%22">Ernst M</searchLink>; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia. matthias.ernst@onjcri.org.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101614637%22">Cancer immunology research</searchLink> [Cancer Immunol Res] 2021 Jul; Vol. 9 (7), pp. 735-747. <i>Date of Electronic Publication: </i>2021 Apr 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101614637 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6074 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223266066%22">23266066 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33906864
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2326-6066.CIR-19-1023
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 735
    Titles:
      – TitleFull: Host IL11 Signaling Suppresses CD4+ T cell-Mediated Antitumor Responses to Colon Cancer in Mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Huynh J
      – PersonEntity:
          Name:
            NameFull: Baloyan D
      – PersonEntity:
          Name:
            NameFull: Chisanga D
      – PersonEntity:
          Name:
            NameFull: Shi W
      – PersonEntity:
          Name:
            NameFull: O'Brien M
      – PersonEntity:
          Name:
            NameFull: Afshar-Sterle S
      – PersonEntity:
          Name:
            NameFull: Alorro M
      – PersonEntity:
          Name:
            NameFull: Pang L
      – PersonEntity:
          Name:
            NameFull: Williams DS
      – PersonEntity:
          Name:
            NameFull: Parslow AC
      – PersonEntity:
          Name:
            NameFull: Thilakasiri P
      – PersonEntity:
          Name:
            NameFull: Eissmann MF
      – PersonEntity:
          Name:
            NameFull: Boon L
      – PersonEntity:
          Name:
            NameFull: Masson F
      – PersonEntity:
          Name:
            NameFull: Chand AL
      – PersonEntity:
          Name:
            NameFull: Ernst M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2021 Jul
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2326-6074
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Cancer immunology research
              Type: main
ResultId 1